Skip to content

LRMR

Larimar Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.83
+0.00%
Ask drillr
1
Insider buys (3m)
0
Insider sells (3m)
$166.9K
Net value (3m)
+21.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 8, 2026Hamilton Thomas Edward · directorPurchase50,000$3.34
May 20, 2026Truitt Joseph · directorA-Award55,150$3.33
May 20, 2026LEFF JONATHAN S · directorA-Award55,150$3.33
May 20, 2026SHERMAN JEFFREY W · directorA-Award55,150$3.33
May 20, 2026Hamilton Thomas Edward · directorA-Award55,150$3.33
May 20, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationA-Award55,150$3.33
May 20, 2026THOMAS FRANK E · directorA-Award55,150$3.33
Mar 2, 2026SHERMAN JEFFREY W · directorPurchase5,000$5.00
Mar 2, 2026Hamilton Thomas Edward · directorPurchase100,000$5.00
Mar 2, 2026THOMAS FRANK E · directorPurchase5,000$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase1,084,010$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase2,000,000$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase831,978$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase1,084,012$5.00
Jan 27, 2026Shankar Gopi · officer: Chief Development OfficerA-Award153,822$3.60
Jan 27, 2026BEN-MAIMON CAROLE · director, officer: President and CEOA-Award100,100$0.00
Jan 27, 2026BEN-MAIMON CAROLE · director, officer: President and CEOA-Award600,600$3.60
Jan 27, 2026Clayton Russell · officer: Chief Medical OfficerA-Award25,637$0.00
Jan 27, 2026Clayton Russell · officer: Chief Medical OfficerA-Award153,822$3.60
Jan 27, 2026Shankar Gopi · officer: Chief Development OfficerA-Award25,637$0.00
Jan 27, 2026Celano Michael · officer: Chief Financial OfficerA-Award37,604$0.00
Jan 27, 2026Celano Michael · officer: Chief Financial OfficerA-Award225,622$3.60
Aug 4, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase2,599,932$3.20
Aug 4, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase3,387,539$3.20
Aug 4, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase3,387,529$3.20
May 15, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationA-Award19,000$1.88
May 14, 2025SHERMAN JEFFREY W · directorA-Award19,000$1.88
May 14, 2025LEFF JONATHAN S · directorA-Award19,000$1.88
May 14, 2025THOMAS FRANK E · directorA-Award19,000$1.88
May 14, 2025Hamilton Thomas Edward · directorA-Award19,000$1.88
Institutional positioning

13F filings over the trailing two quarters

New 44Increased 59Reduced 43Sold out 158
FilerActionSharesFiled
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Increased35,606,974May 15, 2026
BLUE OWL CAPITAL HOLDINGS LPReduced7,120,007May 14, 2026
BLACKROCK, INC.Increased3,752,200May 13, 2026
MILLENNIUM MANAGEMENT LLCReduced3,625,278May 15, 2026
AIGH CAPITAL MANAGEMENT LLCIncreased3,000,000Apr 30, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased2,934,399May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,866,349May 15, 2026
DAFNA CAPITAL MANAGEMENT LLCIncreased2,029,164May 15, 2026
CITADEL ADVISORS LLCIncreased1,716,925Sep 2, 2026
GOLDMAN SACHS GROUP INCReduced1,651,585May 15, 2026
DEEP TRACK CAPITAL, LPNew Position1,500,000May 15, 2026
RTW INVESTMENTS, LPReduced1,500,000May 15, 2026
WOODLINE PARTNERS LPIncreased1,400,850May 15, 2026
GOLDMAN SACHS GROUP INCReduced1,347,215Mar 25, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased1,108,761May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 8, 2026